UJ.com
                        THURSDAY, NOVEMBER 26, 2020
Make Homepage /  Add Bookmark
Front Page
Nation
Business
Search
Subscription
Advertising
About us
Copyright
Contact
 

   Username:
   Password:


Registration

 
GISMETEO.RU
UJ Week
Top 1   

    
Business    

Biopharma gets clearance to for its plasma-based drug to treat COVID-19
Journal Staff Report

KYIV, Nov 16 Ukraines biopharmaceutical company Biopharma Plasma has successfully completed clinical trials of the therapeutics to treat COVID-19, opening door for approval to use the drug to treat the illness, Kostiantyn Yefymenko, the head of the company, said.

The drug, named Bioven, is based on the plasma of people who recovered from COVID-19, is one of the first such therapeutics that has been able to make it to the treatment protocols.




Log in

Print article E-mail article


Currencies (in hryvnias)
  25.11.2020 prev
USD 28.37 28.37
RUR 0.373 0.374
EUR 33.68 33.76

Stock Market
  24.11.2020 prev
PFTS 501.2 501.2
source: PFTS

OTHER NEWS

Ukrainian Journal   
Front PageNationBusinessEditorialFeatureSubscriptionAdvertisingSearchAbout usCopyrightContact
Copyright 2005 Ukrainian Journal. All rights reserved
Programmed by TAC webstudio